-
Organoids Offer Stem Cell Experts a Window into Kidney Disease
Stem cell researchers are now using organoids, lab-grown models of human organs, to better understand kidney disease. In the future, organoids may also provide an important test model for experimental drugs.Full story -
Member Spotlight on Tenneille Ludwig, PhD
What unusual profession helped Dr. Ludwig pay for two years of school? How did she become director of the WiCell Stem Cell Bank and not an IVF clinic as she envisioned? Find out in this month's Member Spotlight.Full story -
2014 ISSCR Election Results Announced
The ISSCR congratulates the winners of the 2014 Elections. New officers and members of the ISSCR Board of Directors will begin their terms in June 2014 following the conclusion of the ISSCR 12th Annual Meeting in Vancover, Canada.Full story -
Details of ISSCR 12th Annual Meeting
The ISSCR 12th Annual Meeting will take place June 18-21, 2014 at the Vancouver Convention Centre in Vancouver, British Columbia, Canada. The meeting will bring together approximately 4,000 stem cell scientists, bioethicists, clinicians and industry professionals from over 50 countries to present and discuss the latest research and technologies within the field.Full story -
Human Disease Modeling Under the Microscope
Induced pluripotent stem cells (iPS cells) have been hailed as a future cell therapy, but they are playing an equally important role in research, revolutionizing the way scientists study human disease. By cultivating human stem cell lines in a dish, scientists are better able to understand diseases, including those with unique genetic markers.Full story -
Late Breaking Abstracts are now being accepted for the ISSCR 12th Annual Meeting
New for 2014, the ISSCR is now accepting Late Breaking Abstracts to be considered for poster presentations at the upcoming ISSCR 12th Annual Meeting, June 18-21 in Vancouver, Canada.Full story -
Two Papers Open a New Window into Pluripotency
The ISSCR is pleased to help spread the news about two papers published online today in Nature that describe the induction of pluripotency in cells from a newborn mouse without the use of extrinsic transcription factors, chemical manipulation or nuclear transfer.Full story -
The ISSCR Announces 2014 Awards Recipients
The ISSCR announces recipients of its 2014 awards, which will be presented at the 12th Annual Meeting in Vancouver, taking place June 18-21, 2014.Full story -
Workshop, "Stem Cell Therapies: Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings"
The ISSCR, the Institute of Medicine and the National Academy of Sciences, is hosting a Washington, DC-based workshop and live webcast examining the practice and consequences of unproven stem cell treatments on November 18, 2013 from 8:30 a.m.-5:30 p.m. EDTFull story -
ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients
The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.Full story
Media Contact
